Abeona Therapeutics ABEO
NASDAQ ABEO
$5.03 +0.02 (+0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Return on Capital Employed [ROCE] of -50.92% for Q2 2026, up 2.98 percentage points from -53.90% a year earlier and up 1.19 percentage points from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Abeona Therapeutics' Return on Capital Employed [ROCE] came in at -66.41%, up 25.47 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -10.39 percentage points (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Return on Capital Employed [ROCE] was -91.89% in FY2024 (+1.11 pp), -92.99% in FY2023 (-13.59 pp), -79.40% in FY2022 (+11.55 pp) and -90.96% in FY2021 (-34.93 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -290.43% in Q3 2022 to a high of -38.44% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last nine quarters, with an average year-over-year change of +18.25 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2023, with a gain of 199.27 percentage points; the weakest was Q3 2022, with a drop of 231.81 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -52.11% (Q1 2026), -45.69% (Q4 2025) and -38.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Abeona Therapeutics 287.85 Mn -426.11 Mn 7.20 Mn -50.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.92%
Mar 31, 2026 -52.11%
Dec 31, 2025 -45.69%
Sep 30, 2025 -38.44%
Jun 30, 2025 -53.90%
Mar 31, 2025 -80.79%
Dec 31, 2024 -65.40%
Sep 30, 2024 -55.80%
Jun 30, 2024 -64.79%
Mar 31, 2024 -85.92%
Dec 31, 2023 -91.31%
Sep 30, 2023 -91.16%
Jun 30, 2023 -102.05%
Mar 31, 2023 -82.48%
Dec 31, 2022 -116.49%
Sep 30, 2022 -290.43%
Jun 30, 2022 -248.54%
Mar 31, 2022 -174.10%
Dec 31, 2021 -108.66%
Sep 30, 2021 -58.62%
API Access

Abeona Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABEO&period=max&api_key=YOUR_API_KEY